Organization Profile

You just read:

IDRI and Medicago Announce FDA Authorization to Initiate a Phase 1 Clinical Trial for an H5N1 Vaccine with GLA Adjuvant

News provided by

Medicago Inc.

Aug 16, 2012, 07:00 ET